Oxford Brain Diagnostics secures FDA 510(k) approval for CDM Insights
Designed using Oxford Brain Diagnostics’ Cortical Disarray Measurement (CDM) technology, CDM Insights is a cloud-native software solution that provides a deeper understanding of the brain’s microstructure from MRI scans
Societal polarisation and its impact on the medical device development industry
Addressing the challenges posed by extreme weather events in the medical device development industry
Economic downturn: challenges and opportunities in the medical device development industry
Biodiversity loss and ecosystem collapse: the impact on the medical device development industry